Molecular Oncology

Team Members

François Radvanyi, PhD

Radvanyi

François Radvanyi Chef d'équipe Team Radvanyi Tel: Back to the list

Key publications

Year of publication 2018

Tom Baladi, Jessy Aziz, Florent Dufour, Valentina Abet, Véronique Stoven, François Radvanyi, Florent Poyer, Ting-Di Wu, Jean-Luc Guerquin-Kern, Isabelle Bernard-Pierrot, Sergio Marco Garrido, Sandrine Piguel (2018 Nov 1)

Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitors.

Bioorganic & medicinal chemistry : 26 : 5510-5530 : DOI : 10.1016/j.bmc.2018.09.031

Year of publication 2014

Sandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, May-Linda Lepage, Clémentine Krucker, Elodie Chapeaublanc, Aurélie Hérault, Aurélie Kamoun, Aurélie Caillault, Eric Letouzé, Nabila Elarouci, Yann Neuzillet, Yves Denoux, Vincent Molinié, Dimitri Vordos, Agnès Laplanche, Pascale Maillé, Pascale Soyeux, Karina Ofualuka, Fabien Reyal, Anne Biton, Mathilde Sibony, Xavier Paoletti, Jennifer Southgate, Simone Benhamou, Thierry Lebret, Yves Allory, François Radvanyi (2014 Jul 11)

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.

Science translational medicine : 244ra91 : DOI : 10.1126/scitranslmed.3008970

Year of publication 2013

Ténin Traoré, Andrea Cavagnino, Nicolas Saettel, François Radvanyi, Sandrine Piguel, Isabelle Bernard-Pierrot, Véronique Stoven, Michel Legraverend (2013 Nov 19)

New aminopyrimidine derivatives as inhibitors of the TAM family.

European journal of medicinal chemistry : 789-801 : DOI : 10.1016/j.ejmech.2013.10.037
Rosa M Suárez, Franciane Chevot, Andrea Cavagnino, Nicolas Saettel, François Radvanyi, Sandrine Piguel, Isabelle Bernard-Pierrot, Véronique Stoven, Michel Legraverend (2013 Mar 1)

Inhibitors of the TAM subfamily of tyrosine kinases: synthesis and biological evaluation.

European journal of medicinal chemistry : 2-25 : DOI : 10.1016/j.ejmech.2012.06.005

Year of publication 2011

Sandra Rebouissou, Aurélie Hérault, Eric Letouzé, Yann Neuzillet, Agnès Laplanche, Karina Ofualuka, Pascale Maillé, Karen Leroy, Audrey Riou, May-Linda Lepage, Dimitri Vordos, Alexandre de la Taille, Yves Denoux, Mathilde Sibony, Frédéric Guyon, Thierry Lebret, Simone Benhamou, Yves Allory, François Radvanyi (2011 Sep 30)

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.

The Journal of pathology : 315-24 : DOI : 10.1002/path.4017